1. Academic Validation
  2. Sphingosine kills intracellular Pseudomonas aeruginosa and Staphylococcus aureus

Sphingosine kills intracellular Pseudomonas aeruginosa and Staphylococcus aureus

  • Pathog Dis. 2024 Feb 7:82:ftae016. doi: 10.1093/femspd/ftae016.
Helene May 1 Yongjie Liu 1 Stephanie Kadow 1 Michael J Edwards 1 Simone Keitsch 1 Barbara Wilker 1 Markus Kamler 2 Heike Grassmé 1 Yuqing Wu 1 Erich Gulbins 1
Affiliations

Affiliations

  • 1 Institute of Molecular Biology, University Hospital Essen, University Duisburg-Essen, 45259 Essen, Germany.
  • 2 Department of Thoracic and Cardiovascular Surgery, Thoracic Transplantation, University Hospital Essen, University Duisburg-Essen, West German Heart and Vascular Center, 45259 Essen, Germany.
Abstract

Sphingosine has been previously shown to kill many strains of pathogenic bacteria including Pseudomonas aeruginosa, Staphyloccus aureus, Acinetobacter, and atypical mycobacteria. However, these studies were performed on isolated or extracellular bacteria and it is unknown whether sphingosine also targets intracellular bacteria. Here, we demonstrate that exogenously-added sphingosine directly binds to extracellular P. aeruginosa and S. aureus, but also targets and binds to intracellular bacteria. Intracellular sphingosine and bacteria were identified by sequential immunostainings. We further show that exogenously-added sphingosine also kills intracellular P. aeruginosa and S. aureus using modified gentamycin assays. Intracellular killing of P. aeruginosa and S. aureus by sphingosine is not mediated by improved phagosomal-lysosomal fusion. In summary, our data indicate that sphingosine binds to and most likely also directly kills extra- and intracellular P. aeruginosa and S. aureus.

Keywords

Pseudomonas aeruginosa; Staphyloccus aureus; Sphingosine; ceramide; cystic fibrosis; sphingolipids.

Figures
Products